Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design -
Abiraterone acetate: a promising drug for the treatment of castration-resistant prostate cancer | Future Oncology
Steroid synthesis pathway and aromatization. Abiraterone is a novel... | Download Scientific Diagram
Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation | Drug Metabolism & Disposition
MAGNITUDE Study of Niraparib/Abiraterone/Prednisone Shows Promise in mCRPC
APCCC 2019: Optimal Steroid Use with Abiraterone
Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer - Jatinder Goyal, Emmanuel S. Antonarakis, 2013
Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer - Annals of Oncology
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone | British Journal of Cancer
Abiraterone Acetate | SpringerLink
Cancers | Free Full-Text | The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
a Mean plasma abiraterone concentration–time plots on steady-state... | Download Scientific Diagram
Abirateron – Wikipedia
Abiraterone Acetate - an overview | ScienceDirect Topics
A Phase II Study of Increased-Dose Abiraterone Acetate in Patients with Castration Resistant Prostate Cancer (CRPC)
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study) | British Journal of Cancer
APCCC 2019: Optimal Steroid Use with Abiraterone
Cancers | Free Full-Text | Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
Treatment Sequencing of Abiraterone Acetate plus Prednisone and Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer - touchONCOLOGY
ZYTIGA® (abiraterone acetate) For Healthcare Professionals
Abiraterone: New Drug in the Treatment of Metastatic Castration-resistant Prostate Cancer - The ASCO Post
